Screener
Revolution Medicines, Inc. RVMD Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Revolution Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Revolution Medicines, Inc.’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-208969
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Cash and cash equivalents | $440,939 | $383,745 |
| Marketable securities | 1,467,145 | 1,641,934 |
| Prepaid expenses and other current assets | 59,829 | 49,358 |
| Total current assets | 1,967,913 | 2,075,037 |
| Property and equipment, net | 31,475 | 33,194 |
| Operating lease right-of-use asset | 129,895 | 132,084 |
| Intangible assets, net | 55,800 | 55,800 |
| Goodwill | 14,608 | 14,608 |
Item 1. Financial Statements.
FAQ
- What is Revolution Medicines, Inc.'s total current assets?
- Revolution Medicines, Inc. (RVMD) reported total current assets of $1.97B in Q1 2026.
- How has Revolution Medicines, Inc.'s total current assets changed year-over-year?
- Revolution Medicines, Inc.'s total current assets decreased by 7.8% year-over-year, from $2.13B to $1.97B.
- What is the long-term trend for Revolution Medicines, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Revolution Medicines, Inc.'s total current assets has grown at a 35.5% compound annual growth rate (CAGR), from $454.12M to $2.08B.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Revolution Medicines, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude